<?xml version="1.0" encoding="UTF-8"?>
<ref id="B74-vaccines-08-00224">
 <label>74.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wang</surname>
    <given-names>Q.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Kuwahara</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Zhu</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Liu</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Xie</surname>
    <given-names>J.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Immunodominant SARS Coronavirus Epitopes in Humans Elicited both Enhancing and Neutralizing Effects on Infection in Non-human Primates</article-title>
  <source>ACS Infect. Dis.</source>
  <year>2016</year>
  <volume>2</volume>
  <fpage>361</fpage>
  <lpage>376</lpage>
  <pub-id pub-id-type="doi">10.1021/acsinfecdis.6b00006</pub-id>
  <?supplied-pmid 27627203?>
  <pub-id pub-id-type="pmid">27627203</pub-id>
 </element-citation>
</ref>
